Spero Therapeutics, Inc.
SPRO—
Spero Therapeutics, Inc.SPRO$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$0.15
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$12.59M
Net income
$8.57M
Net margin
68.1%
Gross margin
—
Dividends & financials
Spero Therapeutics, Inc. (SPRO) reported revenue of $12.59M and net income of $8.57M, or $0.15 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.